(Q36090197)

12 August 2017

1 reference

title

Peptide-based therapeutic vaccines for allergic and autoimmune diseases (English)

1 reference

12 August 2017

1 reference

Mark Larché

1

1 reference

12 August 2017

David C Wraith

series ordinal

2

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

11

1 reference

12 August 2017

issue

4 Suppl

1 reference

12 August 2017

page(s)

S69-76

1 reference

Genetics and genomics of asthma and allergic diseases

12 August 2017

cites work

1 reference

Genetics of autoimmune disease

21 January 2018

1 reference

A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22

21 January 2018

1 reference

A missing link in the hygiene hypothesis?

21 January 2018

1 reference

An immunoepidemiological approach to asthma: identification of in-vitro T-cell response patterns associated with different wheezing phenotypes in children

21 January 2018

1 reference

Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease

21 January 2018

1 reference

T cell regulation as a side effect of homeostasis and competition

21 January 2018

1 reference

The effect of infections on susceptibility to autoimmune and allergic diseases

21 January 2018

1 reference

Regulatory CD4+ T cells and the control of autoimmune disease.

21 January 2018

1 reference

Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease

21 January 2018

1 reference

Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals

21 January 2018

1 reference

Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy

21 January 2018

1 reference

T regulatory cells in atopic dermatitis and subversion of their activity by superantigens

21 January 2018

1 reference

Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis

21 January 2018

1 reference

CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis.

21 January 2018

1 reference

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis

21 January 2018

1 reference

Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study

21 January 2018

1 reference

Long-term clinical efficacy of grass-pollen immunotherapy

21 January 2018

1 reference

PROPHYLACTIC INOCULATION AGAINST HAY FEVER

21 January 2018

1 reference

Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals

21 January 2018

1 reference

Grass pollen immunotherapy for hayfever is associated with increases in local nasal but not peripheral Th1:Th2 cytokine ratios.

21 January 2018

1 reference

IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy

21 January 2018

1 reference

Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity.

21 January 2018

1 reference

Interleukin-10 levels increase in cutaneous biopsies of patients undergoing wasp venom immunotherapy.

21 January 2018

1 reference

In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines.

21 January 2018

1 reference

Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells

21 January 2018

1 reference

Mast cells in the development of adaptive immune responses

21 January 2018

1 reference

Involvement of both 'allergic' and 'autoimmune' mechanisms in EAE, MS and other autoimmune diseases

21 January 2018

1 reference

Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.

21 January 2018

1 reference

Glatiramer acetate (Copaxone): comparison of continuous versus delayed therapy in a six-year organized multiple sclerosis trial

21 January 2018

1 reference

Neurologic consequence of delaying glatiramer acetate therapy for multiple sclerosis: 8-year data

21 January 2018

1 reference

Amelioration of proteolipid protein 139-151-induced encephalomyelitis in SJL mice by modified amino acid copolymers and their mechanisms

21 January 2018

1 reference

Peptide 15-mers of defined sequence that substitute for random amino acid copolymers in amelioration of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

Oral tolerance: immune mechanisms and treatment of autoimmune diseases

21 January 2018

1 reference

Treatment of Uveitis by Oral Administration of Retinal Antigens: Results of a Phase I/II Randomized Masked Trial

21 January 2018

1 reference

Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit

21 January 2018

1 reference

Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic

21 January 2018

1 reference

Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes

21 January 2018

1 reference

Antigen-driven peripheral immune tolerance: suppression of experimental autoimmmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen.

21 January 2018

1 reference

'Educated' dendritic cells act as messengers from memory to naive T helper cells

21 January 2018

1 reference

Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen

21 January 2018

1 reference

Late complications of immune deviation therapy in a nonhuman primate

21 January 2018

1 reference

Induction of Autoimmune Diabetes by Oral Administration of Autoantigen

21 January 2018

1 reference

Vaccination with genetically engineered allergens prevents progression of allergic disease.

21 January 2018

1 reference

Genetically engineered and synthetic allergen derivatives: candidates for vaccination against type I allergy

21 January 2018

1 reference

Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice

21 January 2018

1 reference

The safety and efficacy of ALLERVAX CAT in cat allergic patients

21 January 2018

1 reference

Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and nonmicrobially induced experimental arthritis

21 January 2018

1 reference

Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes

21 January 2018

1 reference

Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)

21 January 2018

1 reference

Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in mice

21 January 2018

1 reference

Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial

21 January 2018

1 reference

Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis

21 January 2018

1 reference

Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production

21 January 2018

1 reference

A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens

21 January 2018

1 reference

Fine specificity of myelin basic protein reactive T-cells: implications for T-cell receptor antagonism

21 January 2018

1 reference

Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo.

21 January 2018

1 reference

The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes

21 January 2018

1 reference

In vivo instruction of suppressor commitment in naive T cells

21 January 2018

1 reference

Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions

21 January 2018

1 reference

Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity

21 January 2018

1 reference

The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase

21 January 2018

1 reference

Influence of a dominant cryptic epitope on autoimmune T cell tolerance

21 January 2018

1 reference

Abundant empty class II MHC molecules on the surface of immature dendritic cells

21 January 2018

1 reference

Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells

21 January 2018

1 reference

Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells

21 January 2018

1 reference

Whence interferon? Variety in the production of interferon in response to viral infection.

21 January 2018

1 reference

Fel d 1-derived T cell peptide therapy induces recruitment of CD4+ CD25+; CD4+ interferon-gamma+ T helper type 1 cells to sites of allergen-induced late-phase skin reactions in cat-allergic subjects

21 January 2018

1 reference

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune responsein multiple sclerosis after administration of an altered peptide ligand ina placebo-controlled, randomized phase II trial

21 January 2018

1 reference

T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis

21 January 2018

1 reference

Genetic analysis of multiplex rheumatoid arthritis families

21 January 2018

1 reference

7 January 2021

Hay fever, hygiene, and household size

1 reference

7 January 2021

Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation

1 reference

7 January 2021

Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health

1 reference

7 January 2021

Does rheumatoid arthritis remit during pregnancy and relapse postpartum?: Results from a nationwide study in the United Kingdom performed prospectively from late pregnancy

1 reference

7 January 2021

Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology

1 reference

7 January 2021

Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen

1 reference

7 January 2021

Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.

1 reference

7 January 2021

Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10

1 reference

7 January 2021

Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo

1 reference

7 January 2021

Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro

1 reference

7 January 2021

Role of interleukin 10 in specific immunotherapy

1 reference

7 January 2021

Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis

1 reference

7 January 2021

Therapy with glatiramer acetate for multiple sclerosis

1 reference

7 January 2021

Oral tolerance: mechanisms and therapeutic applications.

1 reference

7 January 2021

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis

1 reference

7 January 2021

Mucosal Antigen Primes Diabetogenic Cytotoxic T-Lymphocytes Regardless of Dose or Delivery Route

1 reference

7 January 2021

Studies on allergoids from naturally occurring allergens. IV. Efficacy and safety of long-term allergoid treatment of ragweed hay fever

1 reference

7 January 2021

Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I

1 reference

7 January 2021

Treatment of cat allergy with T-cell reactive peptides

1 reference

7 January 2021

Fel d 1 peptides: effect on skin tests and cytokine synthesis in cat-allergic human subjects

1 reference

7 January 2021

Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats

1 reference

7 January 2021

Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom

1 reference

7 January 2021

Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trial

1 reference

7 January 2021

Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects

1 reference

7 January 2021

Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial

1 reference

7 January 2021

Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity

1 reference

7 January 2021

Hierarchy in the ability of T cell epitopes to induce peripheral tolerance to antigens from myelin

1 reference

7 January 2021

Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99

1 reference

7 January 2021

Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope

1 reference

7 January 2021

Differential activities of immunogenic collagen type II peptides in the induction of nasal tolerance to collagen-induced arthritis

1 reference

7 January 2021

Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various beta-cell antigens

1 reference

7 January 2021

Induction of oral tolerance to S-antigen induced experimental autoimmune uveitis by a uveitogenic 20mer peptide

1 reference

7 January 2021

Prevention of experimental myasthenia gravis by nasal administration of synthetic acetylcholine receptor T epitope sequences

1 reference

7 January 2021

Antigen-specific immunosuppression: nasal tolerance to P0 protein peptides for the prevention and treatment of experimental autoimmune neuritis in Lewis rats

1 reference

7 January 2021

Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology

1 reference

7 January 2021

T cell receptor antagonist peptides are highly effective inhibitors of experimental allergic encephalomyelitis

1 reference

7 January 2021

Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand

1 reference

7 January 2021

Transplantation tolerance induced by intranasal administration of HY peptides

1 reference

7 January 2021

T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis

1 reference

7 January 2021

Specific T-cell tolerance may be preceded by a primary response

1 reference

7 January 2021

Regulation of house dust mite responses by intranasally administered peptide: transient activation of CD4+ T cells precedes the development of tolerance in vivo

1 reference

7 January 2021

Late asthmatic reactions induced by inhalation of allergen-derived T cell peptides

1 reference

7 January 2021

Kinetics of peptide uptake and tissue distribution following a single intranasal dose of peptide

1 reference

7 January 2021

Immunological aspects of demyelinating diseases

1 reference

7 January 2021

HLA-DR restricted peptide candidates for bee venom immunotherapy

1 reference

7 January 2021

Peptides containing a dominant T-cell epitope from red cell band 3 have in vivo immunomodulatory properties in NZB mice with autoimmune hemolytic anemia

1 reference

7 January 2021

Characterization of Dendritic Cells that Induce Tolerance and T Regulatory 1 Cell Differentiation In Vivo

1 reference

7 January 2021

Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity.

1 reference

7 January 2021

Affinity for class II MHC determines the extent to which soluble peptides tolerize autoreactive T cells in naive and primed adult mice--implications for autoimmunity

1 reference

7 January 2021

Inhibition of T-cell responsiveness by nasal peptide administration: influence of the thymus and differential recovery of T-cell-dependent functions

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM1226

1 reference

release_allb7zlxvbaq7pikiscrvpuo5a

12 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/allb7zlxvbaq7pikiscrvpuo5a

24 November 2022

mapped directly with Wikidata item

1 reference